Evidence Summary: Red Clover isoflavones have MODERATE evidence for reducing hot flash frequency in menopausal women. Contains genistein, daidzein, formononetin, and biochanin A — phytoestrogenic isoflavones that weakly bind estrogen receptors. Multiple meta-analyses support modest but consistent benefits.
What Is Red Clover?
Red Clover (Trifolium pratense) is a legume plant native to Europe and Asia that contains concentrated isoflavones — plant-derived compounds that structurally resemble estrogen. Unlike soy isoflavones (primarily genistein and daidzein), Red Clover provides all four major isoflavones: genistein, daidzein, formononetin, and biochanin A. The standardized extract Promensil® (40mg isoflavones/day) was used in most clinical trials. Red Clover isoflavones are considered phytoestrogens — they bind to estrogen receptors with much lower affinity than endogenous estrogen, producing weak estrogenic effects that may help offset declining estrogen levels during menopause.
Key Benefits & Clinical Evidence
1. Hot Flash Reduction
🟡 Moderate Evidence. A 2007 meta-analysis in Maturitas (5 RCTs, n=396) found Red Clover isoflavones reduced hot flash frequency by approximately 44% compared to baseline, with a modest advantage over placebo. A 2016 Cochrane review of phytoestrogens broadly confirmed moderate efficacy for vasomotor symptoms, with Red Clover among the better-supported options.
2. Bone Density Support
🟡 Moderate Evidence. A 2004 RCT (n=177, 2 years) found Red Clover extract (Promensil®) slowed bone mineral density loss at the lumbar spine compared to placebo. Effect sizes are smaller than HRT but potentially meaningful for long-term bone health in early post-menopause.
3. Cardiovascular Support
🟡 Moderate Evidence. Several trials report improvements in arterial compliance and lipid profiles (reduced LDL, increased HDL) with Red Clover isoflavone supplementation. A 2005 meta-analysis found significant improvements in arterial stiffness in postmenopausal women.
Clinical Dosage Reference
| Purpose | Clinical Dose | Duration | Evidence |
|---|---|---|---|
| Hot flash reduction | 40–80mg/day isoflavones | 12–24 weeks | 🟡 Moderate |
| Bone density support | 40mg/day (Promensil®) | 12–24 months | 🟡 Moderate |
| Cardiovascular | 40–60mg/day | 3–6 months | 🟡 Moderate |
Safety Considerations
Red Clover isoflavones are generally well-tolerated. Women with hormone-sensitive cancers (breast, uterine, ovarian) or on tamoxifen should avoid phytoestrogens without medical supervision. May interact with warfarin (blood thinners). Not recommended during pregnancy or breastfeeding.
Last Updated: April 2026 | Sources: PubMed, Maturitas, Cochrane Library
DISCLAIMER: For educational purposes only. Not medical advice.
Affiliate Disclosure: BioBoost Reviews may receive a commission for purchases made through the links in this review. This does not affect our editorial independence or the price you pay. We only review products we believe can provide value to our readers.
Important Disclaimer
⚠️ Medical Disclaimer: The information provided in this review is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration. This is a dietary supplement and should not replace professional medical advice. Consult your healthcare provider before starting any new supplement.
